This article provides a systematic guide for researchers, scientists, and drug development professionals on evaluating the clinical utility of prognostic and predictive biomarkers.
This article provides a comprehensive guide for researchers and drug development professionals on the critical process of validating machine learning (ML) models for cancer detection.
Organoid technology has revolutionized biomedical research by providing physiologically relevant in vitro models.
This article provides a comprehensive comparative analysis of computational models for predicting anticancer drug sensitivity from genomic data.
This article provides a detailed comparison of umbrella and basket trial designs, two innovative master protocol frameworks revolutionizing oncology drug development.
This article provides a comprehensive guide for researchers and drug development professionals on optimizing DNA extraction from liquid biopsy samples.
This comprehensive review addresses the pervasive challenge of drug resistance in molecularly targeted therapies, a critical barrier in oncology and beyond.
This article addresses the critical challenge of translating promising preclinical findings into clinical success, a persistent bottleneck in drug development.
This article synthesizes the latest methodologies and validation frameworks for improving the sensitivity and specificity of early detection tests, with a focus on cancer and other diseases.
This comprehensive review addresses the critical challenge of immune-related adverse events (irAEs) associated with cancer immunotherapy, particularly immune checkpoint inhibitors.